Join as an individual or organization
This substance abuse awareness infographic portrays the protective factors of using substances. The most common protective factors are listed on this infographic to educate others on how and why people can prevent or recover from substance...
Source:
Key Points
Que...
Free eBook on How to Integrate Wellness into Drug Prevention
The purpose of this eBook is to gain an understanding of wellness and its essential role in substance use prevention practice for enhancing the mental and physical...
Importance As cannabis becomes more accessible and socially accepted, concerns have grown about its potential implications for adolescent mental health. While prior research has linked adolescent cannabis use to psychiatric...
PURPOSE: Alcohol misuse is widely accepted as an independent risk factor for a wide variety of lung diseases, such as pneumonia and acute respiratory distress syndrome. Alcohol induces changes in the regulatory mechanisms of the...
Buprenorphine is an effective medication for treating opioid use disorder but is underutilized partly due to patient apprehensiveness of the severe withdrawal symptoms it can induce when started, particularly by...
Importance Retention on methadone and buprenorphine has been shown to be associated with reduced overdose and death. Opioid treatment programs (OTPs) are the only health care facilities in the US licensed to dispense methadone...
Importance The requirement for in-person, often daily, attendance at opioid treatment programs (OTPs) makes travel times a barrier to methadone treatment. Research on methadone accessibility has primarily focused on travel via...
A quarter of 11-year-old children in the USA have tried alcohol, typically provided by parents. Parents are the primary source of alcohol socialization for preteens, yet many are unaware of their influence and lack tools to discourage early...
AGENDA
2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics
Topic 1: Large Language Models in...
The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of Interv...
Background
The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides...
Background. Substance use disorders (SUDs) remain a major global health burden. Neurostimulation has emerged as a promising treatment by directly altering brain circuits implicated in addictive behaviors, but current methods are limited in...
This article presents key studies from the National Institute of Justice’s (NIJ) Courts Research Portfolio that examine pretrial, prosecution, and sentencing policies promoting alternatives to incarceration, such as Veterans Treatment...
There is a gap between evidence-based treatment with medications for opioid use disorders (OUDs) and current practices of probation departments who supervise individuals with OUDs. Many probationers with OUDs cannot...
Background and objectives: Drug courts provide an array of substance use treatments and community-based services for probationers struggling with substance use disorders. We assessed substance use treatment services utilization...